Reconstructed first-round book from the research data, not a scrape of today's website. Public portfolio pages over-report winners, and this graph has the same public-data bias. Investor edges are essentially Crunchbase through late 2015, plus Y Combinator.
Research book · 3-year follow-on
Latterell Venture Partners vs Kairos
Not ranked
Whole-book follow-on hit rate 83.3% (5 of 6 labeled deals). 95% Wilson interval 43.6%–97.0%. Vintage-weighted base rate 43.4%. This is not a fund return.
Not ranked. A book needs at least 15 labeled deals with a vintage base rate. This one has 6.
Vs same-vintage base rate
+39.9 pp
83.3% on 6 deals vs 43.4%
Vs median VC book
+30.7 pp
83.3% on 6 deals vs 52.6%
Vs top-quartile VC
+14.6 pp
83.3% on 6 deals vs 68.7%
Vs Y Combinator
+27.0 pp
83.3% on 6 deals vs 56.4%
Ranked when at least 15 labeled deals have a vintage base rate. Rank is the average-rank percentile of shrunk excess (20 pseudo-deals at that book's vintage base rate) among eligible VC books that clear the same minimum. 100 is best. The whole book is never compared to Kairos's top-50 hit rate.
What Kairos would have said
Scores are the model’s percentile at each company’s first observed funding event, not at a later round. That matches this fund’s entry only when the fund was in the first-round syndicate. A deal is flagged when its percentile clears that vintage’s top-50 cutoff. The whole book is not compared to the top-50 hit rate.
Deals with a score
6
Mean model percentile
37
Flagged deals
0no labeled flagged deals
Five-year exit, secondary
Five-year exit labels are observable mainly for 2005–2010. A missing later exit is not counted as a failure. This panel is not the ranking.
Hit rate 33.3% (2 of 6). 95% Wilson interval 9.7%–70.0%.
Vs exit base rate
+20.8 pp
33.3% on 6 deals vs 12.5%
Vs median VC exit book
—
No overlapping vintages
Vs top-quartile exit book
—
No overlapping vintages
Companies
6 labeled follow-on deals, 0 matched without an observable label (dropped, not counted as failures).
| Company | Vintage | Follow-on | Kairos percentile | Flagged |
|---|---|---|---|---|
| Neuraltus Pharmaceuticalsneuraltus.com | 2009 | Yes | 69 | — |
| Ovalis | 2007 | Yes | 56 | — |
| OncoMed Pharmaceuticalsoncomed.com | 2008 | Yes | 32 | — |
| CellBiosciencesproteinsimple.com | 2006 | No | 27 | — |
| Pulmonxpulmonx.com | 2007 | Yes | 23 | — |
| Pathway Medical Technologiespathwaymedical.com | 2009 | Yes | 12 | — |